Clear Street Starts Coverage on Caribou Biosciences with Buy Rating
Clear Street initiates coverage of Caribou Biosciences with a Buy rating and a $13 price target, highlighting strong CAR-T pipeline potential.
NOTRELOAD AI
Teradyne Stock Jumps on Strong AI-Driven Forecast
Teradyne shares surge over 24% after forecasting Q1 revenue and profit above estimates, fueled by AI data center expansion and increased chip testing demand.
TeraWulf Doubles Capacity with Kentucky and Maryland Data Center Acquisitions
TeraWulf acquires two strategic sites adding 1.5 GW capacity, expanding to 2.8 GW total across five locations to support AI and high-performance computing growth.
Acadia Pharmaceuticals Faces EU Setback for Rett Syndrome Drug Trofinetide
Acadia Pharmaceuticals (ACAD) receives negative CHMP vote for trofinetide EU approval despite 1,000+ patients using treatment globally. Company plans re-examination request.
SpaceX Acquires xAI in Record $250 Billion Deal, Creating $1.25 Trillion Tech Giant
Elon Musk merges SpaceX and xAI in historic $250B acquisition, forming $1.25T entity combining space exploration with AI. Deal sets new M&A record, surpassing Vodafone-Mannesmann.
Palantir Reports Explosive Growth: Q4 Revenue Soars 70% Amid AI Boom and Controversy
Palantir Technologies announces 70% Q4 revenue growth and projects 61% increase for 2026, with U.S. commercial revenue up 137%, while defending surveillance tech amid ICE contract scrutiny.